UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Eye (London), 2023-12, Vol.37 (17), p.3551-3557

2023

Volltextzugriff (PDF)

Retinal non-perfusion: recognizing and defining what is important

Eye (London), 2024-06, Vol.38 (9), p.1608-1609

2024

Volltextzugriff (PDF)

Correction: Retinal non-perfusion: recognizing and defining what is important

Eye (London), 2024-06, Vol.38 (9), p.1782-1782

2024

Volltextzugriff (PDF)

Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis

Eye (London), 2023-01, Vol.37 (1), p.6-16

2023

Volltextzugriff (PDF)

What makes a good survey?

Eye (London), 2023-11, Vol.37 (16), p.3299-3301

2023

Volltextzugriff (PDF)

Retinal non-perfusion in diabetic retinopathy

Eye (London), 2022-02, Vol.36 (2), p.249-256

2022

Volltextzugriff (PDF)

Interpreting results from randomized controlled trials: What measures to focus on in clinical practice

Eye (London), 2023-10, Vol.37 (15), p.3055-3058

2023

Volltextzugriff (PDF)

The 5 min meta-analysis: understanding how to read and interpret a forest plot

Eye (London), 2022-04, Vol.36 (4), p.673-675

2022

Volltextzugriff (PDF)

Longitudinal analysis of aqueous humour cytokine expression and OCT-based imaging biomarkers in retinal vein occlusions treated with anti-vascular endothelial growth factor therapy in the IMAGINE study

Eye (London), 2023-06, Vol.37 (9), p.1928-1935

2023

Volltextzugriff (PDF)

Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System

Ophthalmic surgery, lasers & imaging retina, 2018-12, Vol.49 (12), p.913-917

2018

Volltextzugriff (PDF)

Five-Year Outcomes of Surgically Treated Symptomatic Epiretinal Membranes With and Without Internal Limiting Membrane Peeling

Ophthalmic surgery, lasers & imaging retina, 2018-05, Vol.49 (5), p.296-302

2018

Volltextzugriff (PDF)

The clinician’s guide to interpreting a regression analysis

Eye (London), 2022-09, Vol.36 (9), p.1715-1717

2022

Volltextzugriff (PDF)

Baseline retinal vascular bed area on ultra-wide field fluorescein angiography correlates with the anatomical outcome of diabetic macular oedema to ranibizumab therapy: two-year analysis of the DAVE Study

Eye (London), 2023-03, Vol.37 (4), p.678-683

2023

Volltextzugriff (PDF)

Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography

Ophthalmic surgery, lasers & imaging retina, 2014-07, Vol.45 (4), p.312-317

2014

Volltextzugriff (PDF)

Nosocomial Acute-Onset Postoperative Endophthalmitis at a University Teaching Hospital (2002–2009)

American journal of ophthalmology, 2010-09, Vol.150 (3), p.392-398.e2

2010

Volltextzugriff (PDF)

Risk of bias: why measure it, and how?

Eye (London), 2022-02, Vol.36 (2), p.346-348

2022

Volltextzugriff (PDF)

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data

Eye (London), 2020-03, Vol.34 (3), p.480-490

2020

Volltextzugriff (PDF)

Noninferiority randomised trials in ophthalmology

Eye (London), 2023-10, Vol.37 (15), p.3059-3060

2023

Volltextzugriff (PDF)

A clinician’s guide to network meta-analysis

Eye (London), 2022-08, Vol.36 (8), p.1523-1526

2022

Volltextzugriff (PDF)

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Eye (London), 2023-12, Vol.37 (17), p.3705-3705

2023

Volltextzugriff (PDF)

Correction: The 5 min meta-analysis: understanding how to read and interpret a forest plot

Eye (London), 2023-12, Vol.37 (17), p.3704-3704

2023

Volltextzugriff (PDF)

The ophthalmologist’s guide to evaluating the certainty of evidence using the GRADE approach

Eye (London), 2024-06, Vol.38 (9), p.1601-1604

2024

Volltextzugriff (PDF)

When to believe a subgroup analysis: revisiting the 11 criteria

Eye (London), 2022-11, Vol.36 (11), p.2075-2077

2022

Volltextzugriff (PDF)

The need for a pragmatic, individualized treat-and-extend (T&E) treatment paradigm for centre-involving diabetic macular oedema

Eye (London), 2023-08, Vol.37 (12), p.2431-2433

Chaudhary, Varun

2023

Volltextzugriff (PDF)

Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials

Eye (London), 2023-07, Vol.37 (10), p.1966-1974

2023

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaSurgery

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Retinal non-perfusion: recognizing and defining what is important

Correction: Retinal non-perfusion: recognizing and defining what is important

Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis

What makes a good survey?

Retinal non-perfusion in diabetic retinopathy

Interpreting results from randomized controlled trials: What measures to focus on in clinical practice

The 5 min meta-analysis: understanding how to read and interpret a forest plot

Longitudinal analysis of aqueous humour cytokine expression and OCT-based imaging biomarkers in retinal vein occlusions treated with anti-vascular endothelial growth factor therapy in the IMAGINE study

Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System

Five-Year Outcomes of Surgically Treated Symptomatic Epiretinal Membranes With and Without Internal Limiting Membrane Peeling

The clinician’s guide to interpreting a regression analysis

Baseline retinal vascular bed area on ultra-wide field fluorescein angiography correlates with the anatomical outcome of diabetic macular oedema to ranibizumab therapy: two-year analysis of the DAVE Study

Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography

Nosocomial Acute-Onset Postoperative Endophthalmitis at a University Teaching Hospital (2002–2009)

Risk of bias: why measure it, and how?

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data

Noninferiority randomised trials in ophthalmology

A clinician’s guide to network meta-analysis

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Correction: The 5 min meta-analysis: understanding how to read and interpret a forest plot

The ophthalmologist’s guide to evaluating the certainty of evidence using the GRADE approach

When to believe a subgroup analysis: revisiting the 11 criteria

The need for a pragmatic, individualized treat-and-extend (T&E) treatment paradigm for centre-involving diabetic macular oedema

Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials

Aktive Filter

Suchergebnisse filtern